Atara Biotherapeutics

$5.34 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest


About Atara Biotherapeutics

Atara Biotherapeutics, Inc. operates as a biotechnology company. The Company focuses on developing therapies for patients with severe and life-threatening diseases.

Stock Analysis

last close $5.84
1-mo return -32.6%
3-mo return 11.9%
avg daily vol. 4.22M
52-week high 20.04
52-week low 2.83
market cap. $551M
forward pe -
annual div. -
roe -84.1%
ltg forecast -
dividend yield -
annual rev. $72M
inst own. -

Subscribe now for daily local and international financial news